Implantable devices have transformed from being invasive monitoring devices with an on-board memory to non-invasive tissue stimulating telemetry chips. The root cause of the transformation includes the changing needs of both medical experts and physiological conditions for the host. Pacemakers and defibrillators still lead the market when it comes to revenue share, while neuromodulation devices expect rapid growth within the first half of the next decade. Reports on the implantable device segment from Big Market Research give a detailed outlook of the global trends in this segment. The key factors and limitations, affecting the growth of business verticals, has been studied by thorough profiling of financial statistics of market leaders. Statistical performance of the applications and research & development activities that assure opportunities for the market across various geographies have been prioritized for prospective investors and scholars.
No of Reports 0